Investor Overview

Press Releases
  • May 6, 2021 at 10:52 PM EDT
    Refinancing Significantly Reduces Interest Rate and Extends Maturity with Increased Operational Flexibility SUNNYVALE, Calif. , May 6, 2021 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today announced it has entered into a new five-year $80 million term loan and $40 million revolving
  • May 6, 2021 at 10:48 PM EDT
    SUNNYVALE, Calif. , May 6, 2021 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today announced that it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2022 (the "2022 Notes") to exchange an aggregate of $82.1 million
Upcoming Events
There are currently no events to display.

Corporate Profile

Accuray develops, manufactures and sells radiation oncology systems that make cancer treatments shorter, safer, smarter and more effective. Accuray provides treatment delivery technologies that set the industry standard for precision and cover the full range of radiation therapy and radiosurgery treatments, as well as fully integrated software solutions that drive faster, smarter treatment planning.